5143 |
PHOSPHODIESTERASE 4C |
PDE4C |
DPDE1 |
PDE21 |
600128 |
8782 |
ENSG00000105650 |
OTTHUMG00000183353 |
Q08493 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C |
PDE4C_HUMAN |
CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4C (EC 3.1.4.17) (DPDE1) (PDE21). [SOURCE:UNIPROT/SWISSPROT;ACC:Q08493] |
T12081 |
ENSG00000285188 |
Target Class | Enzymes |
Target Subclass | EC:3.1.4.17 |
Target Main Class | Enzymes |
Target Subclass | 3.1.4.17 |
Human Readable Name | DRUGGABLE GENOME |
Interpro Acc | IPR002073 |
Uniprot Status | Swiss-Prot |
Interpro Type | Domain |
Interpro Short Name | PDEase_catalytic_dom |
Interpro Name | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
Uniprot Evidence | 1: Evidence at protein level |
Gene Biotype | PROTEIN_CODING |
DRUGGABLE GENOME |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Novel drug target | Established target |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Trial Name | ibudilast, MN-166, AV411 |
Novel drug target | Established target |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
n/a |
Trial Name | EHT 0202 |
Novel drug target | Established target |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 3',5'-cyclic phosphodiesterase inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 3',5'-cyclic phosphodiesterase inhibitor |
Direct Interaction | yes |
PDE4C | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
PDE4C | Gene Symbol |
Target Class | Enzymes |
Target Subclass | EC:3.1.4.17 |
PDE4C_HUMAN | Uniprot Id |
Q08493 | Uniprot Accession |
ENSG00000105650 | Ensembl Gene Id |
Target Main Class | Enzymes |
Target Subclass | 3.1.4.17 |
CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4C | Uniprot Protein Name |
Q08493 | Uniprot Accession |
5143 | Entrez Gene Id |
Interpro Acc | IPR002073 |
Uniprot Status | Swiss-Prot |
Interpro Type | Domain |
DRUGGABLE GENOME |
PDE4C | Display Id |
ENSG00000105650 | Ensembl Gene Id |
CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4C (EC 3.1.4.17) (DPDE1) (PDE21). [SOURCE:UNIPROT/SWISSPROT;ACC:Q08493] | Description |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
ENSG00000105650 | Gene Symbol |
PDE4C | Ensembl Id |
DRUGGABLE GENOME |
DPDE1 | GENE_SYMBOL |
PDE4C | GENE_SYMBOL |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | UNIPROT |
PDE4C | TTD Gene Abbreviation |
T12081 | TTD Target ID |